Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02740855
Other study ID # Endtidal ethanol
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 2016
Est. completion date October 2018

Study information

Verified date November 2018
Source University Hospital Inselspital, Berne
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

During the ethanol sclerotherapy procedure, the investigators will record doses of and time of ethanol injections and record ethanol concentrations in endtidal breath every 5 minutes. Furthermore after every ethanol injection the concentration will be measured every minute for 5 minutes. To do so, the investigators will attach a breath alcohol testing device to the expiratory carbon dioxide measuring unit. Since this is the new standard of the university hospital Berne all patients undergo the same procedure. There is no study specific intervention. In this study the investigators will only document the breath alcohol levels, doses and timing of ethanol injections. All other data will be obtained from the anesthesia information system. During the two months of the study, the investigators will also record endtidal ethanol concentration after anesthesia in the postoperative care unit discharge from the unit.

The intention is to show the correlation between injected ethanol doses and measured endtidal ethanol concentration over the entire time of the intervention.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date October 2018
Est. primary completion date October 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- undergoing ethanol sclerotherapy at the university hospital Berne

Exclusion Criteria:

- under the age of 18

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Alcomed 3011®
Endtidal ethanol measurement

Locations

Country Name City State
Switzerland Bern University Hospital and University of Bern Bern

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Endtidal ethanol concentrations in mg/dl over time 1 year 2 months
Secondary Bloodpressure in mmHg over time 1 year 2 months
Secondary Bloodpressure in mmHg over injected peripheral ethanol volume 1 year 2 months
Secondary Pulse rate in beats er minute over time 1 year 2 months
Secondary Pulse rate in beats er minute over injected peripheral ethanol volume 1 year 2 months
Secondary Endtidal ethanol concentrations in mg/dl over injected ethanol volume 1 year 2 months